LFCR
LIFECORE BIOMEDICAL, INC. \DE\
+0.29 (+6.85%)4.45USD65.7K成交股數168M市值–本益比(近四季)1.7股價營收比+294.3%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 5 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 34.2M-6% | 23.2M-34% | 31.1M-4% | 8.7M-65% | 36.4M-4% | 35.2M-2% | 32.6M+8% | 24.7M+1% | 37.9M | 35.7M | 30.2M | 24.5M |
| 營業成本 | 22.1M | 18.7M | 23.3M | 5.5M | 22.5M | 25.3M | 21.5M | 19.3M | 20.6M | 23.8M | 20.2M | 21.8M |
| 毛利 | 12.1M-14% | 4.5M-55% | 7.8M-30% | 3.1M-42% | 14.0M-19% | 9.8M-17% | 11.1M+11% | 5.4M+97% | 17.3M | 11.9M | 10.0M | 2.7M |
| 毛利率 | 35.3% | 19.2% | 25.0% | 36.2% | 38.4% | 28.0% | 34.0% | 21.8% | 45.6% | 33.3% | 33.0% | 11.1% |
| 研發費用 | 1.5M | 1.2M | 2.0M | 705K | 2.1M | 2.0M | 1.9M | 2.2M | 2.2M | 2.2M | 2.1M | 2.1M |
| 銷售管理費用 | 8.0M | 7.9M | 8.9M | 3.0M | 9.0M | 10.0M | 11.1M | 14.8M | 12.1M | 9.8M | 9.3M | 9.2M |
| 營業利益 | 2.6M-52% | −4.7M-48% | −3.1M+57% | −590K-95% | 5.3M+148% | −9.0M+909% | −2.0M+32% | −11.6M+34% | 2.1M | −895K | −1.5M | −8.6M |
| 營業利益率 | 7.5% | -20.1% | -9.9% | -6.8% | 14.6% | -25.7% | -6.0% | -46.9% | 5.7% | -2.5% | -4.9% | -35.1% |
| 稅後淨利 | −6.2M+437% | −15.0M+1% | −10.0M+52% | −2.9M-82% | −1.1M-84% | −14.8M-194% | −6.6M-146% | −16.2M+51% | −7.1M | 15.6M | 14.2M | −10.8M |
| 淨利率 | -18.0% | -64.6% | -32.1% | -33.0% | -3.1% | -42.0% | -20.2% | -65.7% | -18.7% | 43.8% | 47.2% | -43.9% |
| 稀釋 EPS | -0.19+217% | -0.43+2% | -0.29+16% | -0.09-83% | -0.06-54% | -0.42-200% | -0.25-164% | -0.53+51% | -0.13 | 0.42 | 0.39 | -0.35 |
| 稀釋股數 | 37.6M | 37.5M | 37.4M | 37.0M | 37.0M | 37.0M | 34.4M | 30.9M | 36.7M | 36.6M | 36.4M | 30.4M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 17.2M | 20.8M | 18.9M | 20.2M | 8.3M | 5.4M | 9.5M | 5.5M | 8.5M | 3.1M | 3.2M | 8.6M |
| 應收帳款 | – | – | – | – | – | – | 30.3M | 25.1M | 31.2M | – | – | – |
| 存貨 | 25.5M | 28.2M | 33.8M | – | 32.3M | 34.6M | 39.2M | 41.6M | 40.0M | 39.7M | 41.4M | 41.7M |
| 總資產 | 230M | 225M | 235M | – | 239M | 238M | 255M | 247M | 254M | 246M | 246M | 246M |
| 有息負債 | 155M | 149M | 136M | – | 130M | 125M | 111M | 106M | 101M | 96.3M | 92.1M | 88.1M |
| 總負債 | 213M | 205M | 198M | – | 192M | 190M | 196M | 207M | 200M | 187M | 203M | 219M |
| 股東權益 | −34.1M | −28.4M | −10.5M | −861K | 1.3M | 2.2M | 15.4M | −3.9M | 11.3M | 17.7M | 1.4M | −13.6M |
| 負債比 | 93.0% | 90.8% | 84.4% | – | 80.2% | 80.0% | 76.6% | 84.0% | 78.8% | 75.9% | 82.8% | 89.2% |
| 淨現金(現金 − 有息負債) | −138M | −128M | −117M | – | −122M | −120M | −101M | −100M | −92.4M | −93.3M | −88.9M | −79.4M |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 4.7M+292% | 1.8M | – | – | 1.2M | – | −613K-93% | – | – | – | −8.3M |
| 資本支出 | – | 1.1M | 1.7M | – | – | 5.5M | – | 3.4M | – | – | – | 5.1M |
| 自由現金流 | – | 3.6M-184% | 25K | – | – | −4.3M | – | −4.0M-70% | – | – | – | −13.4M |
| 折舊攤銷 | – | – | 2.0M | – | – | 2.1M | 2.0M | 2.0M | 1.8M | 2.0M | 2.0M | 2.2M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 15.4% | 0.1% | – | – | -12.1% | – | -16.3% | – | – | – | -54.6% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 129M
| Reportable | 129M | 100.0% | +0.5% |
|---|
產品／服務2025 年度 · 129M
| Contract Development And Manufacturing Organization | 90.1M | 69.9% | -6.7% |
|---|---|---|---|
| HA Manufacturing | 38.8M | 30.1% | +22.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 129M | +0.5% | −38.7M | -30.0% | -1.27 | −13.6M |
| FY2024 | 128M | +24.2% | 12.0M | 9.4% | 0.33 | −18.1M |
| FY2023 | 103M | -7.2% | −99.6M | -96.4% | -3.32 | – |
| FY2022 | 111M | +10.3% | −117M | -104.9% | -3.97 | −48.8M |
| FY2021 | 101M | -37.0% | −32.3M | -32.0% | -1.10 | −2.8M |
| FY2020 | 160M | -71.3% | −38.2M | -23.9% | -1.31 | −29.3M |
| FY2019 | 558M | – | 411K | 0.1% | 0.01 | −28.7M |